School of Pharmaceutical Sciences, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, PR China.
School of Pharmaceutical Sciences, Shandong University of Traditional Chinese Medicine, Jinan, 250355, Shandong, PR China.
Int J Biol Macromol. 2018 Feb;107(Pt B):2475-2483. doi: 10.1016/j.ijbiomac.2017.10.134. Epub 2017 Oct 23.
A sulfated polysaccharide named PRP-S16 was obtained by sulfation of a glucan from Phellinus ribis using the chlorosulfonic acid method. PRP-S16 could significantly block the formation of new vessels in chicken chorioallantoic membrane (CAM). It could also inhibit the proliferation, migration, and tube formation and significantly reduced the mRNA expression of vascular endothelial growth factor (VEGF) in EA.hy926 endothelial cells. Western blotting indicated that PRP-S16 down regulated the protein expression of VEGF and VEGF receptor-1 (VEGFR-1), and inhibited the phosphorylation of VEGFR-2, protein kinase B (Akt) and extracellular signal-regulated kinase (ERK1/2) in EA.hy926 cells. These findings suggest that the mechanism of action of the anti-angiogenesis activity of PRP-S16 is related to the inhibition of VEGF-induced signaling pathway. PRP-S16 might be utilized as an effective antagonist in combating diseases associated with angiogenesis.
一种名为 PRP-S16 的硫酸化多糖,是通过用氯磺酸法对云芝葡聚糖进行硫酸化得到的。PRP-S16 可显著抑制鸡胚尿囊膜(CAM)中新血管的形成。它还可以抑制增殖、迁移和管形成,并显著降低 EA.hy926 内皮细胞中血管内皮生长因子(VEGF)的 mRNA 表达。Western blotting 表明 PRP-S16 下调了 VEGF 和 VEGF 受体-1(VEGFR-1)的蛋白表达,并抑制了 EA.hy926 细胞中 VEGFR-2、蛋白激酶 B(Akt)和细胞外信号调节激酶(ERK1/2)的磷酸化。这些发现表明 PRP-S16 抗血管生成活性的作用机制与抑制 VEGF 诱导的信号通路有关。PRP-S16 可能被用作对抗与血管生成相关疾病的有效拮抗剂。